Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar up82870 (< 20) Submitted: 9/26/2010 2:33:44 PM : Outperform Start Price: $25.94 VRX Score: +71.90

They are being honest!

Featured Broker Partners


Advertisement